Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Kuemmel, S; Tondini, CA; Abraham, J; Nowecki, Z; Itrych, B; Hitre, E; Karaszewska, B; Juarez-Ramiro, A; Morales-Vasquez, F; Perez-Garcia, JM; Cardona-Huerta, S; Monturus, E; Sequi, M; Restuccia, E; Benyunes, M; Martin, M.

Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study

BREAST CANCER RESEARCH AND TREATMENT. 2021; 187(2): 467-476 Nº de citas: 10 [doi:10.1007/s10549-021-06145-3]

Aapro, M; Scotte, F; Escobar, Y; Celio, L; Berman, R; Franceschetti, A; Bell, D; Jordan, K.

Practice Patterns for Prevention of Chemotherapy-Induced Nausea and Vomiting and Antiemetic Guideline Adherence Based on Real-World Prescribing Data

ONCOLOGIST. 2021; 26(6): 1073-1082 Nº de citas: 33 [doi:10.1002/onco.13716]

Garcia-Escobar, I; Brozos-Vazquez, E; Abad, DG; Martinez-Marin, V; Pachon, V; Martin, AJM; Canc Thrombosis Sect Spanish.

Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence

CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(6): 1034-1046 Nº de citas: 4 [doi:10.1007/s12094-020-02506-4]

Garcia-Martin, E; Escudero-Vilaplana, V; Fox, B; Collado-Borrell, R; Marzal-Alfaro, B; Sanchez-Isac, M; Solano-Garzon, ML; del Val, RG; Cano-Gonzalez, JM; de Lucas, NP; Bravo-Guillen, AI; Valero-Salinas, J; Gonzalez-Haba, E; Sanjurjo, M; Martin, M.

Aggressiveness of end-of-life cancer care: what happens in clinical practice?

SUPPORTIVE CARE IN CANCER. 2021; 29(6): 3121-3127 Nº de citas: 6 [doi:10.1007/s00520-020-05828-9]

Escudero-Vilaplana, V; Collado-Borrell, R; Villanueva-Bueno, C; Alvarez, R; Herranz, A; Sanjurjo, M.

Acute pancreatitis in a patient treated with imatinib and gefitinib

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2021; 27(4): 980-983 Nº de citas: 1 [doi:10.1177/1078155220949639]

Bellmunt, J; Esteban, E; Muro XGD; Sepulveda, JM; Maroto, P; Gallardo, E; Alba AGD; Etxaniz, O; Guix, M; Larriba JLG; Arranz, JA; Redrado, M; Calvo, A.

Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI Era

European Urology Oncology. 2021; 4(3): 502-505 Nº de citas: 4 [doi:10.1016/j.euo.2019.07.014]

Taboada AGM; Lominchar PL; Roman LM; García-Alfonso P; Martin AJM; Rodriguez JAB; Pascual JMA.

Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades.

Annals Of Hepato-Biliary-Pancreatic Surgery. 2021; 25(2): 179-191 Nº de citas: 10 [doi:10.14701/ahbps.2021.25.2.179]

Loibl, S; Marme, F; Martin, M; Untch, M; Bonnefoi, H; Kim, SB; Bear, H; McCarthy, N; Olive, MM; Gelmon, K; Garcia-Saenz, J; Kelly, CM; Reimer, T; Toi, M; Rugo, HS; Denkert, C; Gnant, M; Makris, A; Koehler, M; Huang-Bartelett, C; Frean, MJL; Colleoni, M; Werutsky, G; Seiler, S; Burchardi, N; Nekljudova, V; von Minckwitz, G.

Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial

JOURNAL OF CLINICAL ONCOLOGY. 2021; 39(14): 1518-1530 Nº de citas: 249 [doi:10.1200/JCO.20.03639]

Escobar-Alvarez, Y; de Castro-Carpeno, J; Feyjoo, M; Martin-Algarra, S.

Evaluation of patient quality care in Spain in prevention of nausea and vomiting induced by chemotherapy

Journal Of Healthcare Quality Research. 2021; 36(3): 142-149 [doi:10.1016/j.jhqr.2021.01.001]

Verso, M; Munoz, A; Bauersachs, R; Huisman, MV; Mandala, M; Vescovo, G; Becattini, C; Agnelli, G.

Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism

EUROPEAN JOURNAL OF CANCER. 2021; 148: 371-381 Nº de citas: 47 [doi:10.1016/j.ejca.2021.02.026]

Alvarez, YE; Bataller, RD; Altozano, JP; Martinez, SR; Alvarez, AS; Cordellat, AB; Vazquez, EB; Jaime, JC; Escobar, IG; Zambrano, CB.

SEOM clinical guidelines for anaemia treatment in cancer patients (2020)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(5): 931-939 Nº de citas: 11 [doi:10.1007/s12094-021-02580-2]

Gomez-Espana, MA; Montes, AF; Garcia-Carbonero, R; Mercade, TM; Maurel, J; Martin, AM; Pazo-Cid, R; Vera, R; Carrato, A; Feliu, J.

SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(5): 988-1000 Nº de citas: 37 [doi:10.1007/s12094-021-02573-1]

del Alba, AG; Mendez-Vidal, MJ; Vazquez, S; Castro, E; Climent, MA; Gallardo, E; Gonzalez-Billalabeitia, E; Lorente, D; Maroto, JP; Arranz, JA.

SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(5): 969-979 Nº de citas: 22 [doi:10.1007/s12094-021-02561-5]

Majem, M; Manzano, JL; Marquez-Rodas, I; Mujika, K; Munoz-Couselo, E; Perez-Ruiz, E; de la Cruz-Merino, L; Espinosa, E; Gonzalez-Cao, M; Berrocal, A.

SEOM clinical guideline for the management of cutaneous melanoma (2020)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(5): 948-960 Nº de citas: 16 [doi:10.1007/s12094-020-02539-9]

Ferre, AD; Alvarez, RA; Herraez, AC; Jurado, JC; Gonzalez, AE; Martin-Broto, J; Marin, VM; Vega, AM; Garcia, AS; Morales, CV.

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(5): 922-930 Nº de citas: 32 [doi:10.1007/s12094-020-02534-0]

Martin, M; Mayer, IA; Walenkamp, AME; Lapa, C; Andreeff, M; Bobirca, A.

At the bedside: Profiling and treating patients with CXCR4-expressing cancers

JOURNAL OF LEUKOCYTE BIOLOGY. 2021; 109(5): 953-967 Nº de citas: 18 [doi:10.1002/JLB.5BT1219-714R]

Garcia-Alfonso, P; Martin, AJ; Moran, L; Alsar, J; Perez-Solero, G; Codesido, M; Ferrandiz, PA; Cicala, S.

Oral drugs in the treatment of metastatic colorectal cancer

Therapeutic Advances in Medical Oncology. 2021; 13: Nº de citas: 44 [doi:10.1177/17588359211009001]

Palka-Kotlowska, M; Custodio-Cabello, S; Oliveros-Acebes, E; Khosravi-Shahi, P; Cabezon-Gutierrez, L.

Review of risk of COVID-19 in cancer patients and their cohabitants

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2021; 105: 15-20 Nº de citas: 3 [doi:10.1016/j.ijid.2021.01.072]